Cargando…

90K/Mac-2 BP Is a New Predictive Biomarker of Response to Infliximab Therapy in IBD Patients

Inflammatory bowel diseases (IBD), comprising Crohn’s disease (CD) and Ulcerative Colitis (UC), are multifactorial disorders characterized by a chronic inflammatory status with the secretion of cytokines and immune mediators. Biologic drugs targeting pro-inflammatory cytokines, such as infliximab, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pesole, Pasqua Letizia, Liso, Marina, Donghia, Rossella, Guerra, Vito, Lippolis, Antonio, Mastronardi, Mauro, Iacovazzi, Palma Aurelia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966915/ https://www.ncbi.nlm.nih.gov/pubmed/36835367 http://dx.doi.org/10.3390/ijms24043955

Ejemplares similares

Nutritional Regimes Enriched with Antioxidants as an Efficient Adjuvant for IBD Patients under Infliximab Administration, a Pilot Study
por: Liso, Marina, et al.
Publicado: (2022)

Contribution of macro- and micronutrients intake to gastrointestinal cancer mortality in the ONCONUT cohort: Classical vs. modern approaches
por: Donghia, Rossella, et al.
Publicado: (2023)

Ramucirumab and GSK1838705A Enhance the Inhibitory Effects of Low Concentration Sorafenib and Regorafenib Combination on HCC Cell Growth and Motility
por: D’Alessandro, Rosalba, et al.
Publicado: (2019)

Administration Timing Is the Best Clinical Outcome Predictor for Adalimumab Administration in Crohn's Disease
por: Mastronardi, Mauro, et al.
Publicado: (2019)

Expression and significance of 90K/Mac-2BP in prostate cancer
por: HU, JIANXIN, et al.
Publicado: (2013)

Biosimilar infliximab use in paediatric IBD
por: Richmond, Lisa, et al.
Publicado: (2018)

miR-369-3p modulates inducible nitric oxide synthase and is involved in regulation of chronic inflammatory response
por: Scalavino, Viviana, et al.
Publicado: (2020)

Food Network Analysis in Non-Obese Patients with or without Steatosis
por: Donghia, Rossella, et al.
Publicado: (2023)

Serum Cytokine and miRNA Levels Are Differently Expressed in Right- and Left-Sided Colon Cancer
por: De Nunzio, Valentina, et al.
Publicado: (2023)

Infliximab in young paediatric IBD patients: it is all about the dosing
por: Jongsma, Maria M. E., et al.
Publicado: (2020)

The Replacement of Only One Portion of Starchy Carbohydrates with Green Leafy Vegetables Regresses Mid and Advanced Stages of NAFLD: Results from a Prospective Pilot Study
por: De Nucci, Sara, et al.
Publicado: (2023)

Circulating Galectin-1 and 90K/Mac-2BP Correlated with the Tumor Stages of Patients with Colorectal Cancer
por: Wu, Keng-Liang, et al.
Publicado: (2015)

Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma
por: Cagnin, Silvia, et al.
Publicado: (2023)

Effects of Different Biological Therapies on S1/S2 Antibody Response to SARS-CoV-2 Vaccination in a Cohort of Patients with Inflammatory Bowel Disease
por: Labarile, Nunzia, et al.
Publicado: (2022)

Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-making for IBD Outpatients on Maintenance Infliximab Therapy
por: Huang, Vivian W., et al.
Publicado: (2015)

Age-Related Dietary Habits and Blood Biochemical Parameters in Patients with and without Steatosis—MICOL Cohort
por: Donghia, Rossella, et al.
Publicado: (2023)

Remote Monitoring Empowerment of Patients with IBDs during the SARS-CoV-2 Pandemic
por: Mastronardi, Mauro, et al.
Publicado: (2020)

Dietary Habits and Nutrient Intakes Are Associated to Age-Related Central Auditory Processing Disorder in a Cohort From Southern Italy
por: Lampignano, Luisa, et al.
Publicado: (2021)

Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD
por: Ray, Katrina
Publicado: (2021)

Gender and Liver Steatosis Discriminate Different Physiological Patterns in Obese Patients Undergoing Bariatric Surgery: Obesity Center Cohort
por: Donghia, Rossella, et al.
Publicado: (2023)

Plasma Bacterial DNA Load as a Potential Biomarker for the Early Detection of Colorectal Cancer: A Case–Control Study
por: Giacconi, Robertina, et al.
Publicado: (2023)

A Bronze-Tomato Enriched Diet Affects the Intestinal Microbiome under Homeostatic and Inflammatory Conditions
por: Liso, Marina, et al.
Publicado: (2018)

Beneficial Effects of Table Grape Use on Serum Levels of Omega-3 Index and Liver Function: A Randomized Controlled Clinical Trial
por: Notarnicola, Maria, et al.
Publicado: (2022)

Quercetin Exposure Suppresses the Inflammatory Pathway in Intestinal Organoids from Winnie Mice
por: Dicarlo, Manuela, et al.
Publicado: (2019)

GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study
por: Villa, Erica, et al.
Publicado: (2023)

Iron-Enriched Nutritional Supplements for the 2030 Pharmacy Shelves
por: Verna, Giulio, et al.
Publicado: (2021)

Dysbiosis Triggers ACF Development in Genetically Predisposed Subjects
por: De Santis, Stefania, et al.
Publicado: (2021)

Mediterranean Diet and Fatty Liver Risk in a Population of Overweight Older Italians: A Propensity Score-Matched Case-Cohort Study
por: Lampignano, Luisa, et al.
Publicado: (2022)

MAC64 low level commands (revised on 16 10 90)
por: Maugain, J M
Publicado: (1990)

Prediction of gastrointestinal cancers in the ONCONUT cohort study: comparison between logistic regression and artificial neural network
por: Donghia, Rossella, et al.
Publicado: (2023)

Mucosal Healing Did Not Predict Sustained Clinical Remission in Patients with IBD after Discontinuation of One-Year Infliximab Therapy
por: Dai, Cong, et al.
Publicado: (2014)

Interleukin 1β Blockade Reduces Intestinal Inflammation in a Murine Model of Tumor Necrosis Factor–Independent Ulcerative Colitis
por: Liso, Marina, et al.
Publicado: (2022)

MacMath 9.0: a dynamical systems software package for the Macintosh
por: Hubbard, John H, et al.
Publicado: (1992)

Accelerated Infliximab Infusion: Safety, Factors Predicting Adverse Events, Patients’ Satisfaction and Cost Analysis. A Cohort Study in IBD Patients
por: Mazzuoli, S., et al.
Publicado: (2016)

Su1485: COVID-19 VACCINE-INDUCED ANTIBODY RESPONSES ARE IMPAIRED IN IBD PATIENTS TREATED WITH INFLIXIMAB, USTEKINUMAB OR TOFACITINIB, BUT NOT THIOPURINES OR VEDOLIZUMAB
por: Alexander, James L., et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions
por: Notarnicola, Maria, et al.
Publicado: (2021)

A Specific Mutation in Muc2 Determines Early Dysbiosis in Colitis-Prone Winnie Mice
por: Liso, Marina, et al.
Publicado: (2020)

Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients
por: Facchin, Sonia, et al.
Publicado: (2021)

Polyphenol Enriched Diet Administration During Pregnancy and Lactation Prevents Dysbiosis in Ulcerative Colitis Predisposed Littermates
por: De Santis, Stefania, et al.
Publicado: (2021)

Management of inflammatory bowel disease in poor responders to infliximab
por: Guerra, Iván, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8o6eoolba96j4jgbvlueh4sk6v